JPMorgan Chase & Co. 13D and 13G filings for Cartesian Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-07-22 1:11 pm Sale | 2026-06-30 | 13G | CARTESIAN THERAPEUTICS, INC. C RNAC | JPMORGAN CHASE & CO. JPM | 1,486,252 4.800% | -189,384 (-11.30%) | Filing |
| 2025-04-25 2:57 pm Purchase | 2025-03-31 | 13G | CARTESIAN THERAPEUTICS, INC. C RNAC | JPMORGAN CHASE & CO. JPM | 1,675,636 6.100% | 1,675,636 (New Position) | Filing |